Glenmark Pharmaceuticals shares gain Oct-Dec earnings beat forecasts

Written by Reuters | Mumbai | Updated: Jan 28 2014, 16:28pm hrs
Glenmark facilityGlenmark Pharma reported a consolidated net profit of 2.16 billion rupees ($34.57 million) in the October-December quarter.
Shares of Glenmark Pharmaceuticals Ltd surge 5.1 per cent after the company reported better-than-expected earnings.

Glenmark Pharma reported a consolidated net profit of 2.16 billion rupees ($34.57 million) in the October-December quarter, compared with the mean consensus forecasts of 1.81 billion rupees ($28.96 million), compiled by Thomson Reuters StarMine